Cochrane Hypertension
@cochranehtn
Based @UBC, we prepare/maintain/disseminate #SysRevs of effects of healthcare interventions for high blood pressure. RT ≠ endorsement Newsltr: eepurl.com/G2yC1
ID: 314822704
http://hypertension.cochrane.org 10-06-2011 21:30:55
2,2K Tweet
6,6K Takipçi
2,2K Takip Edilen
🎺Our May 29th #ResearchMethods webinar considers the impact of Preprints 📰 🎙️Speaker: Dr. Larissa Shamseer Dr Larissa Shamseer (she/her) 🖱️Registration: ti.ubc.ca/preprints/ #researchmethods #preprints #publishing
ICYMI - #hypertension publication alert🚨 🔍Our The Cochrane Library review on evening vs morning dosing considers evidence from 25 studies that randomised more than 3,000 people: tiny.cc/pm-am-htn #SystematicReview #prescribing #HighBloodPressure
#CochraneDaily On World Hypertension Day (paho.org/en/campaigns/w…), there are about 100 Cochrane Reviews of hypertension in the The Cochrane Library Cochrane Hypertension #Hypertension
ICYMI - #hypertension publication alert 🔎Our The Cochrane Library review on evening vs morning dosing considers evidence from 2⃣5⃣ studies that randomised more than 3,000 people: tiny.cc/pm-am-htn #SystematicReview #prescribing #HighBloodPressure
Ever consider #deprescribing #antihypertensive drugs in older adults? Explore the evidence, benefits, and risks of #deprescribing these drugs in this helpful article from the Australian Prescriber 📖 buff.ly/3RUc5Yb Emily Reeve Danijela Gnjidic Aili Langford
Deprescribing interventions should be tailored to drug class & patient population. Find out the how, what & whys of #deprescribing antihypertensives in frail, older adults in this review, great resource for clinicians developed by Australian colleagues Emily Reeve
ICYMI - PRISMA 2020 Webinar recording! 🚨 Matthew Page discusses the 2020 PRISMA Statement - why it matters + preferred reporting for #SystematicReviews bit.ly/3gTB8Jf